Ellagic Acid Suppresses ApoB Secretion and Enhances ApoA-1 Secretion from Human Hepatoma Cells, HepG2.
The effect of ellagic acid (EA), a naturally occurring polyphenolic compound, on the secretion of apolipoproteins from human hepatocytes, HepG2, was investigated. The levels of apoB and apoA-1 secreted in the cell culture medium were determined by sandwich ELISA. EA did not affect cell viability at the tested concentrations (up to 50 µM). EA suppressed the secretion of apoB and enhanced that of apoA-1 from HepG2 cells. However, cellular apoB levels were increased, suggesting that EA inhibited the trafficking of apoB during the process of secretion. In contrast, the increase in the cellular levels of apoA-1 was consistent with its secreted levels. These results indicate that EA inhibits the secretion of apoB from hepatocytes and increases the secretion of apoA-1. Both of these effects are beneficial for lipoprotein metabolism in the prevention of lifestyle-related diseases. The detailed mechanism underlying these effects of EA on lipoprotein metabolism should be elucidated in the future, but this naturally occurring polyphenolic compound might be antihyperlipidemic. Based on these results, EA is suggested as a candidate food-derived compound for the prevention of hyperlipidemia.
['Ieda|Ayana|A|', 'Wada|Maki|M|', 'Moriyasu|Yuuki|Y|', 'Okuno|Yuuko|Y|', 'Zaima|Nobuhiro|N|', 'Moriyama|Tatsuya|T|0000-0002-6861-926X']
D016632:Apolipoprotein A-I D053299:Apolipoprotein B-100 D006528:Carcinoma, Hepatocellular D004610:Ellagic Acid D056945:Hep G2 Cells D006801:Humans D008113:Liver Neoplasms D009363:Neoplasm Proteins
ellagic acid apoB secretion apoA-1 hepatoma HepG2 HDL MTP VLDL